About Us

Working for you, since 2002

Companies recognise us as market leaders in this field.

We have supported our clients throughout the development process from initial API characterisation to assisting in clinical manufacture. We offer a flexible service package to deliver a programme which best fits the requirements of our clients.


Trusted by you

We provide independent and innovative guidance, which is trusted by our clients.

Our clients can rely on our skills, resources and inventiveness in advanced materials characterisation, formulation and device development, as well as in-silico modelling to develop and characterise OINDPs.


Skills for you

World leading R&D centre in this field, we provide ‘hands-on’ support.

Working with Nanopharm is like recruiting your own specialist respiratory R&D team - enhanced by state-of-the-art technologies and the know-how to develop complex OINDP drug products.


Prof. Rob Price and Dr. Jag Shur are acknowledged as leaders in the field of OINDPs and are recognised for their scientific rigour and nurturing of highly accomplished scientists.



  • meet-a-team-img

    Prof. Rob Price

    Managing Director

    Prof. Robert Price is the founder and hands-on manager of Nanopharm Ltd and has over 15 years experience in research and development of orally inhaled and nasal drug products. He is a Professor of Pharmaceutics at the University of Bath and holds a first-degree in Physics and a PhD in Surface Science. Rob has authored over 100 publications and has invented, developed and licensed novel technologies into the industry.

  • jag-shur

    Dr Jag Shur

    Managing Director

    Dr Jag Shur is a director and hands-on manager of Nanopharm Ltd and has managed business operations and the successful growth of Nanopharm. He has over 15 years of experience in the development of orally inhaled and nasal drug products in both industry and academia, having held positions at Profile Therapeutics (Philips), GlaxoSmithKline and the University of Bath. Jag has a first degree in Chemistry, received his PhD in Inhaled Biopharmaceutics and has authored more than 30 scientific papers.